Advertisement
For patients with nonspecific chronic widespread musculoskeletal pain and vitamin D deficiency

Vitamin D Replacement Improves Chronic Widespread Pain

0
Improvements in patients with chronic widespread musculoskeletal pain and vitamin D deficiency
Cash prices of generic medicines to treat heart failure vary so widely that some patients may not be able to afford to fill all of their prescriptions

AHA: Wide Variation in Prices of Generic Heart Failure Meds

0
Patients can spend from $12 to $400 a month to fill prescriptions
Proton pump inhibitors at higher doses are associated with an increased risk of ischemic stroke

AHA: Proton Pump Inhibitors Tied to Ischemic Stroke Risk

0
Researchers concerned about high doses of meds like esomeprazole and omeprazole
Nearly one-third of Americans newly diagnosed with atrial fibrillation don't realize the condition puts them at increased risk for stroke

AHA: Knowledge of Stroke Risk Lacking Among A-Fib Patients

0
Study finds gaps in what patients know about atrial fibrillation
Half of patients hospitalized with atrial fibrillation aren't receiving oral anticoagulants

AHA: Many A-Fib Patients Not Receiving Oral Anticoagulants

0
Only 46 percent of patients with indications received OACs at discharge from hospital
Medication adherence is increased with receipt of care in a patient-centered medical home

Medication Adherence Up in Patient-Centered Medical Homes

0
Among matched control and medical home practices, adherence up in medical homes
For kidney transplant recipients with hepatitis C virus genotype 1 or 4 infection

Ledipasvir-Sofosbuvir Safe for Kidney Recipients With HCV

0
SVR12 for all kidney transplant recipients with HCV genotype 1, 4 after 12 or 24 weeks of treatment
Bisphosphonates reduce the risk of vertebral

Findings Support Bisphosphonate Use in Men With Osteoporosis

0
Reduced risk seen for vertebral and possibly nonvertebral fractures
For patients with inflammatory joint diseases

ACR: High Demand for CVD-Preventive Meds in IJD

0
High indication for medications, but initiation is infrequent in inflammatory joint disease cohort
Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are associated with increased risk of gastrointestinal adverse events

GI Adverse Events Up With GLP-1 Receptor Agonists

0
Risk varies based on dose, background medications, and type of GLP-1 RA